Morning Rundown: Why Today Matters
Market Pulse: Tech-driven names ripped to new highs while crypto drifted under Fed tightening whispers. AI shares led the charge, and bitcoin’s pullback kept traders restless.
Key Movers: Twist Bioscience’s AI-fueled surge forced bears to cover, and bitcoin teased breakout territory before cooling on rate-hike bets.
Macro & Politics: FDA advisers’ 6–4 vote on a multi-cancer blood screen hints at a biotech re-rating, while Newsom’s Paramount defense adds fresh headline risk.
What’s Next: Watch today’s Fed minutes for hawkish cues; upcoming AI earnings and critical short-interest thresholds could spark another episode.
Market Commentary
Everyone’s fixated on the AI frenzy—just look at “Twist Bioscience Shares Soar 10.27% to New High” (Ibtimes.com.au)—but they’re ignoring the looming biotech catalyst from the Galleri blood test. If the FDA jumps on full approval after that 6–4 advisory panel vote, we’ll see realignment across names that have barely budged. That’s how you uncover wild opportunities beyond the hype.
Consider how “Public Just Wired Prediction Markets Into Its AI Agent Layer” (Forkast.news) and plunging short-seller positions in the AI space (Business Insider) are part of the same machine. Automated bets feeding off sentiment can amplify squeezes faster than you can blink. When your trades start running on collective algorithms, expect head-spinning moves that defy logic.
Here’s the play: track regulatory updates on the multi-cancer blood screen, then monitor AI short interest and Fed commentary like a hawk. Combine those signals, and you’ve got a cheat code for positioning ahead of the next squeeze or biotech rerate. This is where edge lives—don’t sleep on it.
📈 Breaking Financial News
Blood test for multiple cancers clears crucial hurdle on track to FDA approval
If approved, the test could help catch cancers early—but more research is still needed, experts say
Blood test for multiple cancers clears crucial hurdle on track to FDA approval
A U.S. Food and Drug Administration advisory panel voted in favor of recommending that the agency approve a blood test for multiple cancers on Wednesday. The assay, called the Galleri test, is designed to help screen for cancers before symptoms appear, accord…
Newsom denies pressuring California AG into Paramount settlement after liberal backlash
Gov. Gavin Newsom denied on Wednesday pressuring California AG Rob Bonta to settle the Paramount Skydance antitrust lawsuit ahead of the Warner Bros. Discovery merger deal.
XRP vs. Cardano: Which Is the Smarter Buy After Cardano’s 30% Surge?
Cardano just posted a stunning 30% weekly gain while XRP quietly held advantages that most investors missed entirely. Before you chase the momentum, the real…
Public Just Wired Prediction Markets Into Its AI Agent Layer. That’s a New Kind of Rail.
Imagine a portfolio that does not just sit there absorbing market shocks, but constantly adjusts its positions based on the collective intuition of thousands of strangers betting on whether the FDA will approve a new drug or if the Fed will cut rates by a qua…
The man who told readers to buy Amazon at $1.50 says AI’s real breakthrough hasn’t happened yet
Porter Stansberry spent months investigating a little-known technology quietly being adopted by Nvidia and Microsoft — one estimate puts the market at $100 trillion. He calls it the Final Frontier of the technology age.
🔍 Market Analysis & Insights
Here's how bearish short-sellers are navigating the shifting AI trade
Data from S&P Global shows that short sellers are spreading out their bearish bets beyond chips and other hot hardware plays.
Bitcoin Breakout Cools as Fed Rate-Hike Bets Climb
Bitcoin has slipped back below $85,000 after tagging an eight-month high near $87,400 last week, with rising odds of an October Fed hike taking some air out of the rally.
Twist Bioscience Shares Soar 10.27% to New High, Extending a Remarkable 493% Yearlong Rally Fueled by AI
Twist Bioscience shares rose 10.27% to $174.78, extending a near-493% annual rally after an Eli Lilly partnership, higher revenue guidance and improving operating trends.
Public Launches AI Agents for Prediction Markets
At launch, Public is focusing on trading events that move the markets NEW YORK, Sept. 24, 2026 /PRNewswire/ — Public, the world's first agentic brokerage, today announced the launch of AI Agents for Prediction Markets, enabling members to trade on events tha…
NEAR Price Prediction: NEAR Holds $4.40 as MemeToro Opens AI Agent Code to Users
NEAR is holding near $4.32 to $4.40 after a powerful short-squeeze rally. The token gained more than 11% in one day as an estimated $666… The post NEAR Price Prediction: NEAR Holds $4.40 as MemeToro Opens AI Agent Code to Users appeared first on Bitcoin Fou…
The Third Pillar of Crypto: A Little-Known Altcoin Drawing Attention From Visa, PayPal and Google
Bitcoin just topped $125,000 and Ethereum is rallying — but the bigger story may be an early-stage altcoin big corporations are already using for payments and cloud computing. Weiss Ratings names it in its new report, Crypto's New Big Three.
💰 Investment Opportunities
FDA Advisers Back Multi-Cancer Blood Test for Adults 50 and Up but Split 6 to 4 on Effectiveness
An FDA panel voted 7-2 that the Galleri cancer blood test's benefits outweigh its risks, but split 6-4 on effectiveness. What it means for adults 50 and older.
Dollar hovers near 2-month peak, Swiss Franc falls, Norwegian crown rises
Sept 24 : The dollar steadied near a two-month high on Thursday after a sharp rally fuelled by expectations of additional Federal Reserve interest rate hikes following strong economic data and a hawkish shift in rhetoric.Meanwhile, the Swiss Franc fell agains…
Nearly Three in Four Americans 50 and Older Say They Would Take a Dementia Vaccine, Though None Exists
A JAMA Network Open survey found that 72% of adults 50 and older would likely take a dementia vaccine. None exists yet. What families should know.
Niwali Tejocote Capsules and Pieces Recalled After FDA Tests Find Toxic Yellow Oleander, the Brand's Second Recall
Niwali Tejocote Capsules and Pieces sold on eBay and Everymarket contain toxic yellow oleander, FDA tests show. See lot codes and next steps.
A Blood Test for 50 Cancers Goes Before the FDA: An Oncologist Explains What the Evidence Really Shows
The Galleri multi-cancer blood test found more cancers and cut stage 4 diagnoses in the largest trial of its kind, but it missed its main goal. A cancer specialist explains how to read the results and what they mean for patients considering the test.
A $6 Miner Just Found 114 Tons of Gold Near Mount Rushmore
Wall Street veteran Whitney Tilson took a camera crew to the site. He says new technology uncovered a payload worth $22 billion — nearly two-thirds of all the gold mined in America last year — and the firm behind it still trades around $6.